2012
DOI: 10.1038/bonekey.2012.144
|View full text |Cite
|
Sign up to set email alerts
|

Association between cardiovascular diseases and osteoporosis—reappraisal

Abstract: Many studies published over the past 20 years show a significant positive association between cardiovascular diseases (CVD) and osteoporosis. This association is important because it concerns two major public health problems. The investigation of shared biomarkers (clinical, radiological, biochemical) may improve identification of subjects at high risk of both diseases. The investigation of shared pathophysiological mechanisms may help to understand the pathophysiology of these diseases and to establish new … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
18
0
6

Year Published

2015
2015
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(24 citation statements)
references
References 68 publications
0
18
0
6
Order By: Relevance
“…Epidemiological studies suggest an association between clinical cardiovascular disease (CVD) and osteoporotic fracture risk (16). Given that clinical CVD and fractures are end-stage disorders preceded by subclinical disorders – atherosclerosis that is neither symptomatic nor clinically recognized, and osteoporosis, respectively – these subclinical disorders may also be related to one another.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Epidemiological studies suggest an association between clinical cardiovascular disease (CVD) and osteoporotic fracture risk (16). Given that clinical CVD and fractures are end-stage disorders preceded by subclinical disorders – atherosclerosis that is neither symptomatic nor clinically recognized, and osteoporosis, respectively – these subclinical disorders may also be related to one another.…”
Section: Introductionmentioning
confidence: 99%
“…Most of the studies that have examined the association of subclinical atherosclerosis with fracture risk have focused on vascular calcification as the marker of vascular disease (1–4). Calcification of the fibrous capsule of an atherosclerotic plaque or of the medial layer of the arterial wall is a process different from thickening of the intima and media, plaque formation, and vessel stenosis (11, 12).…”
Section: Introductionmentioning
confidence: 99%
“…Although these conditions commonly co-occur in older adults, growing evidence suggests an association between vascular calcification and skeletal fragility that is independent of age and other shared risk factors. Older adults with the greatest bone loss have the greatest progression of vascular calcification 1,2 and the incidence of cardiovascular (CV) events is greater in women with lower bone mass 3 and in men with higher levels of bone resorption 4,5 . The association between both pathologies also depends on the mechanisms involved in the regulation of bone and CV metabolism 5 .…”
Section: Introductionmentioning
confidence: 99%
“…Older adults with the greatest bone loss have the greatest progression of vascular calcification 1,2 and the incidence of cardiovascular (CV) events is greater in women with lower bone mass 3 and in men with higher levels of bone resorption 4,5 . The association between both pathologies also depends on the mechanisms involved in the regulation of bone and CV metabolism 5 . We have previously shown that the nutrients and micronutrients that benefit the CV system generally also benefit bone [6][7][8] .…”
Section: Introductionmentioning
confidence: 99%
“…Thirdly, coexistence of osteoporosis and CVD may be due to common genetic factors. Genome-wide association studies have identified several genes and single nucleotide polymorphisms associated with BMD, and CVD risk factors or metabolic traits, including high density lipoprotein, low density lipoprotein, triglycerides, type 1 diabetes, type 2 diabetes, systolic blood pressure, diastolic blood pressure and waist hip ratio [13,15,16,17]. Furthermore osteoprotegerin and receptor activator of nuclear factor kappa B ligand regulate osteoclast activation and function but are also involved in the vascular calcification process and atherosclerosis.…”
mentioning
confidence: 99%